Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1078787 | 0.96 | APP (0.39) | APPEPHX2PTGS1PDE4ALMNA | |
| SCHEMBL97942 | 0.96 | APP (0.39) | APPEPHX2PTGS1PDE4ALMNA | |
| SCHEMBL2818663 | 0.94 | APP (0.38) | APPEPHX2PTGS1PDE4ALMNA | |
| Potassium SCHEMBL30106126 | 0.94 | APP (0.38) | APPEPHX2PTGS1PDE4ALMNA | |
| Hydrochloric Acid SCHEMBL9571802 | 0.94 | APP (0.38) | APPEPHX2PTGS1PDE4ALMNA | |
| SCHEMBL29515023 | 0.94 | APP (0.38) | APPEPHX2PTGS1PDE4ALMNA | |
| SCHEMBL35763 | 0.86 | PTGS1 (0.35) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL1078938 | 0.86 | PTGS1 (0.35) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL23242898 | 0.84 | PTGS1 (0.33) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL29538945 | 0.84 | CYP2D6 (0.35) | APPPTGS1PDE4ALMNASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 859 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724588-A1 | A METHOD OF ENHANCED SEPARATION OF FULL ADENO-ASSOCIATED VIRUS (AAV) CAPSIDS | Sartorius BIA Separations d.o.o. (SI) | 2026-04-15 | — | — | EP | claimed |
| US-12582670-B2 | Lignin solvation using aqueous biologically compatible buffers | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2026-03-24 | — | — | US | claimed |
| US-20250376770-A1 | NON-TRIAZOLE YELLOW METAL CORROSION INHIBITOR COMPOSITIONS AND METHODS OF TREATMENT | CHEMTREAT, INC. (US) | 2025-12-11 | — | — | US | claimed |
| WO-2025217418-A1 | SAMPLE PREPARATION FOR NUCLEIC ACIDS | Life Technologies Corporation (US) | 2025-10-16 | — | — | WO | claimed |
| WO-2024252024-A1 | A METHOD OF ENHANCED SEPARATION OF FULL ADENO-ASSOCIATED VIRUS (AAV) CAPSIDS | SARTORIUS BIA SEPARATIONS D.O.O. (SI) | 2024-12-12 | — | — | WO | claimed |
| EP-4397631-A2 | METHODS TO REDUCE N-HETEROCYCLES | BL TECHNOLOGIES, Inc. (US) | 2024-07-10 | — | — | EP | claimed |
| CN-117923676-A | Methods and compositions for reducing azole and AOX corrosion inhibitors | BL 科技公司 | 2024-04-26 | — | — | CN | claimed |
| CN-111801301-B | Methods and compositions for reducing azole and AOX corrosion inhibitors | BL 科技公司 | 2023-11-24 | — | — | CN | claimed |
| US-20230331600-A1 | METHODS AND COMPOSITIONS TO REDUCE AZOLES AND AOX CORROSION INHIBITORS | BL TECHNOLOGIES, INC. | 2023-10-19 | — | — | US | claimed |
| US-11760666-B2 | Methods and compositions to reduce azoles and AOX corrosion inhibitors | BL TECHNOLOGIES, INC. (US) | 2023-09-19 | — | — | US | claimed |
| US-20030181579-A1 | Oligomeric dispersant | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2003-09-25 | — | — | US | claimed |
| EP-1345952-A2 | ISOLATION OF NUCLEIC ACIDS | DNA Research Innovations Limited (GB) | 2003-09-24 | — | — | EP | claimed |
| US-20030144385-A1 | Oligomeric dispersant | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2003-07-31 | — | — | US | claimed |
| US-20030054395-A1 | Isolation of nucleic acids | Life Technologies Corporation | 2003-03-20 | — | — | US | claimed |
| US-20030008320-A1 | Isolation of nucleic acids | Life Technologies Corporation | 2003-01-09 | — | — | US | claimed |
| US-20020195341-A1 | Alkaline pH, free solution capillary electrophoresis method | SEBIA (FR) | 2002-12-26 | — | — | US | claimed |
| US-6451881-B1 | Oligomeric dispersant | MBT HOLDINGAG (CH) | 2002-09-17 | — | — | US | claimed |
| WO-2002048164-A2 | ISOLATION OF NUCLEIC ACIDS | DNA RESEARCH INNOVATIONS LIMITED (GB) | 2002-06-20 | — | — | WO | claimed |
| US-20010018513-A1 | Isolation of nucleic acids | Life Technologies Corporation | 2001-08-30 | — | — | US | claimed |
| US-6133347-A | CEMENT AND A DISPERSANT COMPRISING THE REACTION PRODUCT OF A WATER SOLUBLE NONIONIC POLYMER NONADSORBING TO CEMENT PARTICLES, SUCH AS POLYOXYALKYLENE GLYCOLS, AND SPECIFIED FUNCTIONAL MOIETY THAT ADSORB ONTO A PARTICLE | MBT HOLDING AG (CH) | 2000-10-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12582670-B2 | Lignin solvation using aqueous biologically compatible buffers | HCLS1, ASNS, EPAS1 | APP 2046/4885EPHX2 351/4885PTGS1 1174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.